ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

The Cancer Letter To End Print Edition In January

November 20, 2009

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997